ANDA 213432, held by Amphastar Pharms Inc. Succinylcholine Chloride.
As of Nov 16, 2026, ANDA 213432 (Succinylcholine Chloride), held by Amphastar Pharms Inc, was first approved by FDA on Jun 8, 2020, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 8, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Succinylcholine Chloride20MG/ML · injectable;injection | Succinylcholine Chloride | Discontinued |
| Aug 15, 2025 | Supplement 1Labeling · Standard review | Approved | None posted |
| Aug 15, 2025 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jun 8, 2020 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters